Zobrazeno 1 - 10
of 354
pro vyhledávání: '"Claudio Fuganti"'
Autor:
Raúl Garillo, Oswaldo Tadeu Greco, Oscar Oseroff, Fernando Lucchese, Claudio Fuganti, José Luis Montenegro, Abdel Fuenmayor Arocha, José Carlos Buenfil Medina, Juan José Sirena
Publikováno v:
Journal of Cardiac Arrhythmias, Vol 17, Iss 4 (2020)
La enfermedad de Chagas es una parasitosis endémica de América Latina que se extiende desde México y el sur de los Estados Unidos hasta los confines de la Patagonia en el extremo sur del continente americano. Durante la etapa crónica la disfunci
Externí odkaz:
https://doaj.org/article/6bbf70cc67764cf0be8ea3a055883cd0
Publikováno v:
Antibiotics, Vol 6, Iss 1, p 7 (2017)
Lipiarmycin A3 and tiacumicin B possess the same chemical structure and have been considered identical till recently, when some authors have suggested the possibility of a minor difference between the chemical structures of the two antibiotics. In th
Externí odkaz:
https://doaj.org/article/ad299b55165143858a6dd331364df7a1
Publikováno v:
CHIMIA, Vol 47, Iss 4 (1993)
Externí odkaz:
https://doaj.org/article/8afdac38f4884a0c94061014b7f40f24
Publikováno v:
Antibiotics; Volume 6; Issue 1; Pages: 7
Antibiotics (Basel) 6 (2017). doi:10.3390/antibiotics6010007
info:cnr-pdr/source/autori:Serra S.; Malpezzi L.; Bedeschi A.; Fuganti C.; Fonte P./titolo:Final demonstration of the co-identity of lipiarmycin A3 and tiacumicin B(Fidaxomicin) through single crystal X-ray analysis/doi:10.3390%2Fantibiotics6010007/rivista:Antibiotics (Basel)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:6
Antibiotics
Antibiotics, Vol 6, Iss 1, p 7 (2017)
Antibiotics (Basel) 6 (2017). doi:10.3390/antibiotics6010007
info:cnr-pdr/source/autori:Serra S.; Malpezzi L.; Bedeschi A.; Fuganti C.; Fonte P./titolo:Final demonstration of the co-identity of lipiarmycin A3 and tiacumicin B(Fidaxomicin) through single crystal X-ray analysis/doi:10.3390%2Fantibiotics6010007/rivista:Antibiotics (Basel)/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:6
Antibiotics
Antibiotics, Vol 6, Iss 1, p 7 (2017)
Lipiarmycin A3 and tiacumicin B possess the same chemical structure and have been considered identical till recently, when some authors have suggested the possibility of a minor difference between the chemical structures of the two antibiotics. In th
Autor:
Paolo Ronchi, Elisabetta Brenna, Alessia Manfredi, Fabio Parmeggiani, Francesco G. Gatti, Giovanni Fronza, Claudio Fuganti
Publikováno v:
Journal of molecular catalysis. B, Enzymatic
84 (2012): 94–101. doi:10.1016/j.molcatb.2012.02.003
info:cnr-pdr/source/autori:Brenna, Elisabetta; Fronza, Giovanni; Fuganti, Claudio; Gatti, Francesco G.; Manfredi, Alessia; Parmeggiani, Fabio; Ronchi, Paolo/titolo:On the stereochemistry of the Baker's Yeast-mediated reduction of regioisomeric unsaturated aldehydes: Examples of enantioselectivity switch promoted by substrate-engineering/doi:10.1016%2Fj.molcatb.2012.02.003/rivista:Journal of molecular catalysis. B, Enzymatic (Print)/anno:2012/pagina_da:94/pagina_a:101/intervallo_pagine:94–101/volume:84
84 (2012): 94–101. doi:10.1016/j.molcatb.2012.02.003
info:cnr-pdr/source/autori:Brenna, Elisabetta; Fronza, Giovanni; Fuganti, Claudio; Gatti, Francesco G.; Manfredi, Alessia; Parmeggiani, Fabio; Ronchi, Paolo/titolo:On the stereochemistry of the Baker's Yeast-mediated reduction of regioisomeric unsaturated aldehydes: Examples of enantioselectivity switch promoted by substrate-engineering/doi:10.1016%2Fj.molcatb.2012.02.003/rivista:Journal of molecular catalysis. B, Enzymatic (Print)/anno:2012/pagina_da:94/pagina_a:101/intervallo_pagine:94–101/volume:84
The Baker's Yeast (BY) reduction of (Z)-2-chloromethyl-3-arylacrylaldehydes was found to afford (R)-2-methyl-3-aryl-propanols showing high enantiomeric excess values. Deuterium incorporation experiments were performed, in order to investigate the mec
Autor:
Elisabetta Brenna, Claudio Fuganti
Publikováno v:
Current Organic Chemistry. 15:987-1005
Autor:
Alessandro Sacchetti, Claudio Fuganti
Publikováno v:
Journal of Molecular Catalysis B: Enzymatic
The results of our studies on the biocatalytic enantioselective synthesis of different 3-aryl-2-nitropropanols are presented. These compounds could be obtained in moderate to good ee both by baker's yeast mediated reduction of (E)-2-nitro-3-arylprop-
Thermal and structural characterization of two polymorphs of Atovaquone and of its chloro derivative
Publikováno v:
Journal of Thermal Analysis and Calorimetry. 102:203-210
Atovaquone, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, is an antimicrobial medicament used to treat or prevent pneumocystis carinii pneumonia, toxoplasmosis and malaria. Two polymorphs of Atovaquone (crystal phases I and III) were
Publikováno v:
Tetrahedron: Asymmetry
A new synthetic route of to pharmaceutical intermediates (S)-1a–b and (S)-14 is reported. The reaction pathway is based on the baker’s yeast-mediated reduction of the α-alkoxy cinnamaldehydes 9a–c to give the corresponding (S)-alcohols in good
Publikováno v:
Tetrahedron: Asymmetry
A new scaleable synthetic route to the title compounds has been developed. The reaction pathway is based on the α-chymotrypsin-catalysed hydrolysis of the racemic ethyl 2-ethoxy-3-( p -methoxyphenyl)propanoate or of the racemic ethyl 2-methoxy-3-( p